May  ||| S:0 E:4 ||| NNP
the  ||| S:4 E:8 ||| DT
drain  ||| S:8 E:14 ||| NN
be  ||| S:14 E:17 ||| VB
a  ||| S:17 E:19 ||| DT
way  ||| S:19 E:23 ||| NN
in  ||| S:23 E:26 ||| IN
for  ||| S:26 E:30 ||| IN
microbes  ||| S:30 E:39 ||| NNS
in  ||| S:39 E:42 ||| IN
surgical  ||| S:42 E:51 ||| JJ
infections ||| S:51 E:61 ||| NNS
?  ||| S:61 E:63 ||| .
Surgical  ||| S:63 E:72 ||| JJ
site  ||| S:72 E:77 ||| NN
infection  ||| S:77 E:87 ||| NN
( ||| S:87 E:88 ||| -LRB-
SSI ||| S:88 E:91 ||| NNP
)  ||| S:91 E:93 ||| -RRB-
is  ||| S:93 E:96 ||| VBZ
among  ||| S:96 E:102 ||| IN
the  ||| S:102 E:106 ||| DT
most  ||| S:106 E:111 ||| RBS
frequent  ||| S:111 E:120 ||| JJ
hospital-acquired  ||| S:120 E:138 ||| JJ
infections  ||| S:138 E:149 ||| NNS
occurring  ||| S:149 E:159 ||| VBG
in  ||| S:159 E:162 ||| IN
surgical  ||| S:162 E:171 ||| JJ
patients  ||| S:171 E:180 ||| NNS
and  ||| S:180 E:184 ||| CC
leads  ||| S:184 E:190 ||| VBZ
to  ||| S:190 E:193 ||| TO
increased  ||| S:193 E:203 ||| JJ
morbidity ||| S:203 E:212 ||| NN
,  ||| S:212 E:214 ||| ,
mortality ||| S:214 E:223 ||| NN
,  ||| S:223 E:225 ||| ,
and  ||| S:225 E:229 ||| CC
costs ||| S:229 E:234 ||| NNS
.  ||| S:234 E:236 ||| .
We  ||| S:236 E:239 ||| PRP
aimed  ||| S:239 E:245 ||| VBD
to  ||| S:245 E:248 ||| TO
identify  ||| S:248 E:257 ||| VB
risk  ||| S:257 E:262 ||| NN
factors  ||| S:262 E:270 ||| NNS
for  ||| S:270 E:274 ||| IN
SSI  ||| S:274 E:278 ||| NNP
in  ||| S:278 E:281 ||| IN
patients  ||| S:281 E:290 ||| NNS
undergoing  ||| S:290 E:301 ||| VBG
surgical  ||| S:301 E:310 ||| JJ
procedures ||| S:310 E:320 ||| NNS
,  ||| S:320 E:322 ||| ,
with  ||| S:322 E:327 ||| IN
a  ||| S:327 E:329 ||| DT
particular  ||| S:329 E:340 ||| JJ
attention  ||| S:340 E:350 ||| NN
to  ||| S:350 E:353 ||| TO
the  ||| S:353 E:357 ||| DT
use  ||| S:357 E:361 ||| NN
of  ||| S:361 E:364 ||| IN
drains ||| S:364 E:370 ||| NN
.  ||| S:370 E:372 ||| .
This  ||| S:372 E:377 ||| DT
study  ||| S:377 E:383 ||| NN
includes  ||| S:383 E:392 ||| VBZ
all  ||| S:392 E:396 ||| DT
patients  ||| S:396 E:405 ||| NNS
undergoing  ||| S:405 E:416 ||| VBG
abdominal  ||| S:416 E:426 ||| JJ
surgical  ||| S:426 E:435 ||| JJ
procedures  ||| S:435 E:446 ||| NNS
in  ||| S:446 E:449 ||| IN
2  ||| S:449 E:451 ||| CD
surgical  ||| S:451 E:460 ||| JJ
wards  ||| S:460 E:466 ||| NN
in  ||| S:466 E:469 ||| IN
a  ||| S:469 E:471 ||| DT
teaching  ||| S:471 E:480 ||| NN
hospital  ||| S:480 E:489 ||| NN
in  ||| S:489 E:492 ||| IN
central  ||| S:492 E:500 ||| JJ
Italy ||| S:500 E:505 ||| NNP
.  ||| S:505 E:507 ||| .
Collected  ||| S:507 E:517 ||| JJ
data  ||| S:517 E:522 ||| NNS
included  ||| S:522 E:531 ||| VBD
patient ||| S:531 E:538 ||| NN
's  ||| S:538 E:541 ||| POS
demographic  ||| S:541 E:553 ||| JJ
and  ||| S:553 E:557 ||| CC
clinical  ||| S:557 E:566 ||| JJ
characteristics ||| S:566 E:581 ||| NNS
,  ||| S:581 E:583 ||| ,
procedure  ||| S:583 E:593 ||| NN
characteristics ||| S:593 E:608 ||| NNS
,  ||| S:608 E:610 ||| ,
administration  ||| S:610 E:625 ||| NN
of  ||| S:625 E:628 ||| IN
perioperative  ||| S:628 E:642 ||| JJ
antibiotic  ||| S:642 E:653 ||| JJ
prophylaxis ||| S:653 E:664 ||| NN
,  ||| S:664 E:666 ||| ,
and  ||| S:666 E:670 ||| CC
microorganism  ||| S:670 E:684 ||| JJ
isolated ||| S:684 E:692 ||| NN
.  ||| S:692 E:694 ||| .
The  ||| S:694 E:698 ||| DT
outcome  ||| S:698 E:706 ||| NN
of  ||| S:706 E:709 ||| IN
interest  ||| S:709 E:718 ||| NN
was  ||| S:718 E:722 ||| VBD
SSI ||| S:722 E:725 ||| NNP
.  ||| S:725 E:727 ||| .
A  ||| S:727 E:729 ||| DT
total  ||| S:729 E:735 ||| NN
of  ||| S:735 E:738 ||| IN
872  ||| S:738 E:742 ||| CD
abdominal  ||| S:742 E:752 ||| JJ
surgery  ||| S:752 E:760 ||| NN
procedures  ||| S:760 E:771 ||| NNS
were  ||| S:771 E:776 ||| VBD
surveyed  ||| S:776 E:785 ||| VBN
during  ||| S:785 E:792 ||| IN
the  ||| S:792 E:796 ||| DT
study  ||| S:796 E:802 ||| NN
period ||| S:802 E:808 ||| NN
.  ||| S:808 E:810 ||| .
Drains  ||| S:810 E:817 ||| NNP
were  ||| S:817 E:822 ||| VBD
placed  ||| S:822 E:829 ||| VBN
in  ||| S:829 E:832 ||| IN
37.0 ||| S:832 E:836 ||| CD
%  ||| S:836 E:838 ||| NN
of  ||| S:838 E:841 ||| IN
cases ||| S:841 E:846 ||| NNS
.  ||| S:846 E:848 ||| .
SSI  ||| S:848 E:852 ||| NNP
rate  ||| S:852 E:857 ||| NN
was  ||| S:857 E:861 ||| VBD
6.4 ||| S:861 E:864 ||| CD
%  ||| S:864 E:866 ||| NN
globally  ||| S:866 E:875 ||| NNS
and  ||| S:875 E:879 ||| CC
13.6 ||| S:879 E:883 ||| CD
%  ||| S:883 E:885 ||| NN
among  ||| S:885 E:891 ||| IN
the  ||| S:891 E:895 ||| DT
patients  ||| S:895 E:904 ||| NNS
with  ||| S:904 E:909 ||| IN
drains ||| S:909 E:915 ||| NN
,  ||| S:915 E:917 ||| ,
versus  ||| S:917 E:924 ||| CC
2.4 ||| S:924 E:927 ||| CD
%  ||| S:927 E:929 ||| NN
in  ||| S:929 E:932 ||| IN
those  ||| S:932 E:938 ||| DT
without  ||| S:938 E:946 ||| IN
a  ||| S:946 E:948 ||| DT
drain  ||| S:948 E:954 ||| NN
( ||| S:954 E:955 ||| -LRB-
P    ||| S:955 E:957 ||| NNP
< ||| S:957 E:958 ||| SYM
.001 ||| S:959 E:963 ||| NNP
) ||| S:963 E:964 ||| -RRB-
.  ||| S:964 E:966 ||| .
In  ||| S:966 E:969 ||| IN
72.1 ||| S:969 E:973 ||| CD
%  ||| S:973 E:975 ||| NN
of  ||| S:975 E:978 ||| IN
cases  ||| S:978 E:984 ||| NNS
antibiotic  ||| S:984 E:995 ||| JJ
prophylaxis  ||| S:995 E:1007 ||| NN
was  ||| S:1007 E:1011 ||| VBD
administered ||| S:1011 E:1023 ||| VBN
.  ||| S:1023 E:1025 ||| .
The  ||| S:1025 E:1029 ||| DT
logistic  ||| S:1029 E:1038 ||| JJ
regression  ||| S:1038 E:1049 ||| JJ
analysis  ||| S:1049 E:1058 ||| NN
( ||| S:1058 E:1059 ||| -LRB-
P    ||| S:1059 E:1061 ||| NNP
< ||| S:1061 E:1062 ||| SYM
.001 ||| S:1063 E:1067 ||| NNP
)  ||| S:1067 E:1069 ||| -RRB-
shown  ||| S:1069 E:1075 ||| VBN
insertion  ||| S:1075 E:1085 ||| VBN
of  ||| S:1085 E:1088 ||| IN
a  ||| S:1088 E:1090 ||| DT
drain  ||| S:1090 E:1096 ||| NN
( ||| S:1096 E:1097 ||| -LRB-
odds  ||| S:1097 E:1102 ||| JJ
ratio  ||| S:1102 E:1108 ||| NN
[ ||| S:1108 E:1109 ||| -LRB-
OR ||| S:1109 E:1111 ||| NNP
] ||| S:1111 E:1112 ||| -RRB-
,  ||| S:1112 E:1114 ||| ,
5.14 ||| S:1114 E:1118 ||| NNP
;  ||| S:1118 E:1120 ||| :
95 ||| S:1120 E:1122 ||| CD
%  ||| S:1122 E:1124 ||| NN
confidence  ||| S:1124 E:1135 ||| NN
interval  ||| S:1135 E:1144 ||| NNS
[ ||| S:1144 E:1145 ||| -LRB-
CI ||| S:1145 E:1147 ||| NNP
] ||| S:1147 E:1148 ||| -RRB-
,  ||| S:1148 E:1150 ||| ,
2.63-10.08 ||| S:1150 E:1160 ||| CD
) ||| S:1160 E:1161 ||| -RRB-
,  ||| S:1161 E:1163 ||| ,
prolonged  ||| S:1163 E:1173 ||| JJ
surgery  ||| S:1173 E:1181 ||| NN
( ||| S:1181 E:1182 ||| -LRB-
OR ||| S:1182 E:1184 ||| NNP
,  ||| S:1184 E:1186 ||| ,
1.98 ||| S:1186 E:1190 ||| CD
;  ||| S:1190 E:1192 ||| :
95 ||| S:1192 E:1194 ||| CD
%  ||| S:1194 E:1196 ||| NN
CI ||| S:1196 E:1198 ||| NNP
,  ||| S:1198 E:1200 ||| ,
1.09-3.59 ||| S:1200 E:1209 ||| CD
) ||| S:1209 E:1210 ||| -RRB-
,  ||| S:1210 E:1212 ||| ,
and  ||| S:1212 E:1216 ||| CC
American  ||| S:1216 E:1225 ||| NNP
Society  ||| S:1225 E:1233 ||| NNP
of  ||| S:1233 E:1236 ||| IN
Anesthesiologists  ||| S:1236 E:1254 ||| NNP
score  ||| S:1254 E:1260 ||| VBP
equal  ||| S:1260 E:1266 ||| JJ
to  ||| S:1266 E:1269 ||| TO
3  ||| S:1269 E:1271 ||| CD
( ||| S:1271 E:1272 ||| -LRB-
OR ||| S:1272 E:1274 ||| NNP
,  ||| S:1274 E:1276 ||| ,
6.13 ||| S:1276 E:1280 ||| NNP
;  ||| S:1280 E:1282 ||| :
95 ||| S:1282 E:1284 ||| CD
%  ||| S:1284 E:1286 ||| NN
CI ||| S:1286 E:1288 ||| NNP
,  ||| S:1288 E:1290 ||| ,
2.33-16.11 ||| S:1290 E:1300 ||| CD
)  ||| S:1300 E:1302 ||| -RRB-
as  ||| S:1302 E:1305 ||| IN
independent  ||| S:1305 E:1317 ||| JJ
risk  ||| S:1317 E:1322 ||| NN
factors  ||| S:1322 E:1330 ||| NNS
for  ||| S:1330 E:1334 ||| IN
SSI ||| S:1334 E:1337 ||| NNP
,  ||| S:1337 E:1339 ||| ,
whereas  ||| S:1339 E:1347 ||| IN
antibiotic  ||| S:1347 E:1358 ||| JJ
prophylaxis  ||| S:1358 E:1370 ||| NN
was  ||| S:1370 E:1374 ||| VBD
protective  ||| S:1374 E:1385 ||| JJ
( ||| S:1385 E:1386 ||| -LRB-
OR ||| S:1386 E:1388 ||| NNP
,  ||| S:1388 E:1390 ||| ,
0.53 ||| S:1390 E:1394 ||| CD
;  ||| S:1394 E:1396 ||| :
95 ||| S:1396 E:1398 ||| CD
%  ||| S:1398 E:1400 ||| NN
CI ||| S:1400 E:1402 ||| NNP
,  ||| S:1402 E:1404 ||| ,
0.29-0.99 ||| S:1404 E:1413 ||| CD
) ||| S:1413 E:1414 ||| -RRB-
.  ||| S:1414 E:1416 ||| .
This  ||| S:1416 E:1421 ||| DT
study  ||| S:1421 E:1427 ||| NN
revealed  ||| S:1427 E:1436 ||| VBD
surgical  ||| S:1436 E:1445 ||| JJ
drains  ||| S:1445 E:1452 ||| NN
as  ||| S:1452 E:1455 ||| IN
a  ||| S:1455 E:1457 ||| DT
risk  ||| S:1457 E:1462 ||| NN
factor  ||| S:1462 E:1469 ||| NN
for  ||| S:1469 E:1473 ||| IN
SSI ||| S:1473 E:1476 ||| NNP
,  ||| S:1476 E:1478 ||| ,
pointing  ||| S:1478 E:1487 ||| VBG
out  ||| S:1487 E:1491 ||| RP
the  ||| S:1491 E:1495 ||| DT
need  ||| S:1495 E:1500 ||| NN
of  ||| S:1500 E:1503 ||| IN
a  ||| S:1503 E:1505 ||| DT
clearer  ||| S:1505 E:1513 ||| JJR
understanding  ||| S:1513 E:1527 ||| NN
of  ||| S:1527 E:1530 ||| IN
drain  ||| S:1530 E:1536 ||| NN
role  ||| S:1536 E:1541 ||| NN
in  ||| S:1541 E:1544 ||| IN
the  ||| S:1544 E:1548 ||| DT
dynamics  ||| S:1548 E:1557 ||| NNS
of  ||| S:1557 E:1560 ||| IN
SSI  ||| S:1560 E:1564 ||| NNP
occurrence ||| S:1564 E:1574 ||| NN
,  ||| S:1574 E:1576 ||| ,
with  ||| S:1576 E:1581 ||| IN
the  ||| S:1581 E:1585 ||| DT
purpose  ||| S:1585 E:1593 ||| NN
of  ||| S:1593 E:1596 ||| IN
decreasing  ||| S:1596 E:1607 ||| VBG
infection  ||| S:1607 E:1617 ||| NN
risk  ||| S:1617 E:1622 ||| NN
through  ||| S:1622 E:1630 ||| IN
targeted  ||| S:1630 E:1639 ||| JJ
preventive  ||| S:1639 E:1650 ||| JJ
interventions ||| S:1650 E:1663 ||| NNS
.  ||| S:1663 E:1665 ||| .
